Dianthus Therapeutics, a clinical-stage biotechnology company, has recently released its 10-K report, detailing its operations and financial performance. The company, founded in 2019 and headquartered ...

Beta Bionics said the FDA cleared Mint, its new patch pump, and that it expects U.S. commercialization to begin in the first quarter of 2027. The company said Mint will be launched with manufacturing ...

Keurig Dr Pepper said it will receive $925 million in pre-tax proceeds from a pair of transactions with Chobani, including the sale of its minority stake in Chobani for $800 million and the sale of ...

Stanley Black & Decker said it has agreed to sell its Excel Industries business to Bad Boy Mowers, in a deal that would remove a turf-care unit expected to generate about $300 million in fiscal 2026 ...

SS Innovations said its SSI Mantra surgical robotic system has now been installed in 12 countries after a recent deployment in Sri Lanka, up from its prior footprint that included India and other ...

Summit Therapeutics Inc. (NASDAQ: SMMT) has announced that the U.S. Food and Drug Administration (FDA) has accepted its biologics license application (BLA) seeking approval for Ivonescimab in ...

Transocean Ltd (NYSE: RIG) and Valaris Limited (NYSE: VAL) have announced a definitive agreement to combine the two companies under an all-stock transaction valued at approximately $5.8 billion. The ...

Brixmor Property Group and Everview Partners agreed to buy Slate Grocery REIT in a transaction valued at $2.34 billion, splitting the portfolio into two pieces with sharply different ownership ...

Morgan Stanley reported first-quarter 2026 net revenues of $20.58 billion, up 16% from $17.74 billion a year earlier, as net income applicable to the firm rose 29% to $5.57 billion from $4.32 billion.

Flex said Amy B. Schwetz will join as chief financial officer on Oct. 5, 2026, and is expected to remain CFO after the company separates its cloud and power infrastructure segment. The company also ...

Orion Group Holdings, Inc. has completed the acquisition of J.E. McAmis, Inc. and JEM Marine Leasing LLC for approximately $60 million. This acquisition is expected to advance Orion’s long-term ...

Axogen said it will buy privately held Biocircuit Technologies for $200 million in cash, adding Nervetape, the first FDA-approved device for sutureless peripheral nerve repair, to its portfolio. The ...